CD69 and melanoma: In contrast, CD69+ NK cells were shown to negatively correlate in melanoma patients with progression-free survival (PFS) less than 6 months, while CD69+ NK cells were positively correlated with PFS in melanoma patients with PFS greater than 6 months [223].